Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

The Swedish National Board of Health and Welfare have presented the first ever national guidelines for the treatment and care of psoriasis. Though there have been guidelines created for the treatment of psoriasis by different shareholders in the past, this is the first time the that guidelines have been published by the The National Board of Health and Welfare.

Though current research has paved the way for new and effective treatments for psoriasis, the disease is still under-treated, and there are large regional differences in psoriasis care throughout Sweden. Different regions and clinics have different treatment options and accessibility, and there is often no continuity in the care and follow-up of the treatment. Some patients receive the same treatment year after year, although the treatment is not sufficiently effective. In addition, many people with psoriasis often have joint and muscle joint discomfort. People with severe psoriasis are also more likely to experience other health concerns, such as high blood pressure, diabetes, obesity and mental illness. Psoriasis patients are treated in primary care, rheumatological care and dermatological care.

Cooperation between these parts of health care have been inadequate in the past. The  guidelines created by the  Swedish National Board of Health and Welfare will have a significant role in strengthening cooperation between different specialists treating one patient, and will aid to ensure equality of healthcare. With these guidelines, the National Board of Health and Welfare wants to help reduce the large regional differences in psoriatic care. The guidelines contain recommendations in the following areas: living habits and complicity, investigation and follow-up, topical treatment (treatment with, for example, skin cream), treatment for specifically localized psoriasis, light treatment and climate care, and systemic treatment. The guidelines also emphasize the importance of giving the various initiatives against psoriasis to the right patient group.

The process of creating these guideline has taken several years, and will continue with follow-up routines within the the years to come. In an evaluation that is expected to be completed in the fall of 2019, the National Board of Health and Welfare will describe to what extent the regions follow these guidelines, which will then provide a basis for moving towards future improvements in the health and medical care sector.

Marcus Schmitt-Egenolf, a current IPC Councilor, was the lead dermatologist in managing the creation of these new guidelines.

Learn more about the Swedish National Board of Health and Welfare national guidelines for the treatment and care of psoriasis >>>

UPCOMING EVENT

The mechanistic model(s) of psoriasis: Autoimmune and/or inflammatory?

Wednesday, September 18, 2019
2:00 pm - 6:00 pm
Bordeaux, france
Register Now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

This website uses cookies. Please ensure your cookies are enabled. 
OK